Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Han Huang

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Tzu Chi Medical Journal|September 21, 2020
Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferationChun-Chun Chang, Cheng-Der Liu, Sheng-Feng Pan, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 18, 2026
Response to "Comment on 'Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)'"Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Plos One|November 21, 2022
Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot studyYi-Feng Wu, Ming-Huei Gu, Chao-Zong Liu, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibilityNan-Yao Lee, Ching-Chi Lee, Wei-Han Huang, et al.
International Journal of Hematology|December 6, 2013
Thalidomide treatment in a myelofibrosis patient with leukemia transformationWei-Han Huang, Ming-Shing Li, Sung-Chao Chu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC mattersNan-Yao Lee, Ching-Chi Lee, Wei-Han Huang, et al.
Frontiers in Medicine|January 3, 2022
Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential ThrombocytosisChih-Lung Shen, Tsung-Cheng Hsieh, Tso-Fu Wang, et al.
Thrombosis Research|November 1, 2019
Higher CD56+ or CD2+ lymphocyte percentage predicts poor steroid response in patients with immune thrombocytopeniaYi-Feng Wu, Wei-Han Huang, Ming-Huei Gu, et al.
Microorganisms|February 25, 2023
Conversion of <i>Escherichia coli</i> into Mixotrophic CO<sub>2</sub> Assimilation with Malate and Hydrogen Based on Recombinant Expression of 2-Oxoglutarate:Ferredoxin Oxidoreductase Using Adaptive Laboratory EvolutionYu-Chen Cheng, Wei-Han Huang, Shou-Chen Lo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2025
Jaceosidin, a natural polymethoxyflavone, suppresses leukemia cell growth and impairs lipid metabolism-dependent survival in AML and cytarabine-resistant cellsTrung Q Phan, Je-Wen Liou, Liang-In Lin, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Tzu Chi Medical Journal|September 21, 2020
Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferationChun-Chun Chang, Cheng-Der Liu, Sheng-Feng Pan, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 18, 2026
Response to "Comment on 'Consensus of the hematology society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)'"Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Plos One|November 21, 2022
Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot studyYi-Feng Wu, Ming-Huei Gu, Chao-Zong Liu, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibilityNan-Yao Lee, Ching-Chi Lee, Wei-Han Huang, et al.
International Journal of Hematology|December 6, 2013
Thalidomide treatment in a myelofibrosis patient with leukemia transformationWei-Han Huang, Ming-Shing Li, Sung-Chao Chu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC mattersNan-Yao Lee, Ching-Chi Lee, Wei-Han Huang, et al.
Frontiers in Medicine|January 3, 2022
Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential ThrombocytosisChih-Lung Shen, Tsung-Cheng Hsieh, Tso-Fu Wang, et al.
Thrombosis Research|November 1, 2019
Higher CD56+ or CD2+ lymphocyte percentage predicts poor steroid response in patients with immune thrombocytopeniaYi-Feng Wu, Wei-Han Huang, Ming-Huei Gu, et al.
Microorganisms|February 25, 2023
Conversion of <i>Escherichia coli</i> into Mixotrophic CO<sub>2</sub> Assimilation with Malate and Hydrogen Based on Recombinant Expression of 2-Oxoglutarate:Ferredoxin Oxidoreductase Using Adaptive Laboratory EvolutionYu-Chen Cheng, Wei-Han Huang, Shou-Chen Lo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2025
Jaceosidin, a natural polymethoxyflavone, suppresses leukemia cell growth and impairs lipid metabolism-dependent survival in AML and cytarabine-resistant cellsTrung Q Phan, Je-Wen Liou, Liang-In Lin, et al.
Pageof 4